Comparison of plasma tissue factor levels in unstable and stable angina pectoris

被引:119
作者
Misumi, K
Ogawa, H
Yasue, H
Soejima, H
Suefuji, H
Nishiyama, K
Takazoe, K
Kugiyama, K
Tsuji, I
Kumeda, K
Nakamura, S
机构
[1] Kumamoto Univ, Sch Med, Div Cardiol, Kumamoto 860, Japan
[2] Kyoto Univ, Primate Res Inst, Aichi, Japan
[3] ChemoSeroTherapeut Res Inst, Kumamoto, Japan
关键词
D O I
10.1016/S0002-9149(97)00801-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have reported that the plasma levels of plasma fibrinopeptide A and plasminogen activator inhibitor activity increase in patients with unstable angina and acute myocardial infarction, Tissue factor (TF) is a low-molecular-weight glycoprotein that binds to and acts on essential cofactor VII, and the resulting complex activates factors IX and X, initiating the coagulation cascade, We measured plasma TF antigen levels in 21 patients with unstable angina (on admission and after treatment), 27 patients with stable exertional angina, and 27 control subjects, The 3 groups were matched for age, gender, and other clinical variables, The plasma TF antigen levels were higher in the unstable angina group than in the stable exertional angina and control groups (240 +/- 75 vs 184 +/- 46 and 177 +/- 37 pg/ml, p <0.01), There were no significant differences in the plasma TF antigen levels between the stable exertional angina and the control groups, Furthermore, the plasma TF antigen levels were reexamined after treatment in the 21 patients with unstable angina, The mean level in these 21 patients decreased after 2 weeks of treatment (from 240 +/- 75 to 206 +/- 57 pg/ml, p <0.01), This study suggests that the plasma TF antigen levels correlate with disease activity in patients with unstable angina, The increased plasma if antigen levels in patients with unstable angina may reflect intravascular procoagulant activity, (C) 1998 by Excerpta Medica, Inc.
引用
收藏
页码:22 / 26
页数:5
相关论文
共 23 条
  • [1] MAINTENANCE OF CORONARY PATENCY AFTER FIBRINOLYSIS WITH TISSUE FACTOR PATHWAY INHIBITOR
    ABENDSCHEIN, DR
    MENG, YY
    TORRBROWN, S
    SOBEL, BE
    [J]. CIRCULATION, 1995, 92 (04) : 944 - 949
  • [2] DIFFERENTIAL EXPRESSION OF TISSUE FACTOR PROTEIN IN DIRECTIONAL ATHERECTOMY SPECIMENS FROM PATIENTS WITH STABLE AND UNSTABLE CORONARY SYNDROMES
    ANNEX, BH
    DENNING, SM
    CHANNON, KM
    SKETCH, MH
    STACK, RS
    MORRISSEY, JH
    PETERS, KG
    [J]. CIRCULATION, 1995, 91 (03) : 619 - 622
  • [3] Tissue-factor antigen and activity in human coronary atherosclerotic plaques
    Ardissino, D
    Merlini, PA
    Ariens, R
    Coppola, R
    Bramucci, E
    Mannucci, PM
    [J]. LANCET, 1997, 349 (9054) : 769 - 771
  • [4] ROLE OF TISSUE FACTOR IN DISSEMINATED INTRAVASCULAR COAGULATION
    ASAKURA, H
    KAMIKUBO, Y
    GOTO, A
    SHIRATORI, Y
    YAMAZAKI, M
    JOKAJI, H
    SAITO, M
    UOTANI, C
    KUMABASHIRI, I
    MORISHITA, E
    AOSHIMA, K
    NAKAMURA, S
    MATSUDA, T
    [J]. THROMBOSIS RESEARCH, 1995, 80 (03) : 217 - 224
  • [5] THE ROLE OF TISSUE FACTOR IN THE PRODUCTION OF THROMBIN
    CARSON, SD
    BROZNA, JP
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (02) : 281 - 292
  • [6] EDGINGTON TS, 1991, THROMB HAEMOSTASIS, V66, P67
  • [7] FUNCTIONAL-SIGNIFICANCE OF THE KUNITZ-TYPE INHIBITORY DOMAINS OF LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR
    GIRARD, TJ
    WARREN, LA
    NOVOTNY, WF
    LIKERT, KM
    BROWN, SG
    MILETICH, JP
    BROZE, GJ
    [J]. NATURE, 1989, 338 (6215) : 518 - 520
  • [8] PREVENTION OF ARTERIAL REOCCLUSION AFTER THROMBOLYSIS WITH RECOMBINANT LIPOPROTEIN ASSOCIATED COAGULATION INHIBITOR
    HASKEL, EJ
    TORR, SR
    DAY, KC
    PALMIER, MO
    WUN, TC
    SOBEL, BE
    ABENDSCHEIN, DR
    [J]. CIRCULATION, 1991, 84 (02) : 821 - 827
  • [9] EXTRINSIC-PATHWAY ACTIVATION IN CANCER WITH HIGH FACTOR VIIA AND TISSUE FACTOR
    KAKKAR, AK
    DERUVO, N
    CHINSWANGWATANAKUL, V
    TEBBUTT, S
    WILLIAMSON, RCN
    [J]. LANCET, 1995, 346 (8981): : 1004 - 1005
  • [10] Measurement of the free form of TFPI antigen in hyperlipidemia - Relationship between free and endothelial cell-associated forms of TFPI
    Kokawa, T
    Enjyoji, K
    Kumeda, K
    Kamikubo, Y
    HaradaShiba, M
    Koh, H
    Tsushima, M
    Yamamoto, A
    Kato, H
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (06) : 802 - 808